Saudi Arabia Pharmaceuticals & Healthcare Report Q4 2012 - New Market Report Now Available
BMI View: Saudi Arabia's transition to an increasingly privatised and comprehensive healthcare system will drive the demand for both patented and generic drugs. The country is investing heavily in healthcare infrastructure and we expect this will be borne out in double-digit growth forecasts across our three headline indicators.
View full press release